TrialClinical and vaccine immunology : CVI2012
Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis.
Joseph A Bellanti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it